Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings

被引：27

作者：

Eratne, Dhamidhu ^{[1
,2
,3
,4
]}

Loi, Samantha M. ^{[1
,2
,3
,4
]}

Qiao-Xin Li ^{[4
]}

Stehmann, Christiane ^{[4
,5
,6
]}

Malpas, Charles B. ^{[7
]}

Santillo, Alexander ^{[8
,9
]}

Janelidze, Shorena ^{[8
,9
]}

Cadwallader, Claire ^{[1
]}

Walia, Nirbaanjot ^{[1
]}

Ney, Blair ^{[10
,11
]}

Lewis, Victoria ^{[5
,6
]}

Senesi, Matteo ^{[5
,6
]}

Fowler, Christopher ^{[10
]}

McGlade, Amelia ^{[4
]}

Varghese, Shiji ^{[4
]}

Ravanfar, Parsa ^{[1
,2
,3
]}

Kelso, Wendy ^{[1
]}

Farrand, Sarah ^{[1
,2
,3
]}

Keem, Michael ^{[1
]}

Kang, Matthew ^{[1
]}

Goh, Anita M. Y. ^{[1
,2
,3
]}

Dhiman, Kunal ^{[12
,13
]}

Gupta, Veer ^{[12
,13
]}

Watson, Rosie ^{[14
]}

Yassi, Nawaf ^{[14
,15
,16
]}

Kaylor-Hughes, Cath ^{[17
]}

Kanaan, Richard ^{[18
]}

Perucca, Piero ^{[19
,20
,21
]}

Dobson, Hannah ^{[1
,22
]}

Vivash, Lucy ^{[21
]}

Ali, Rashida ^{[21
]}

O'Brien, Terence J. ^{[21
]}

Hansson, Oskar ^{[8
,9
]}

Zetterberg, Henrik ^{[23
,24
,25
,26
]}

Blennow, Kaj ^{[23
,24
]}

Walterfang, Mark ^{[1
,2
,3
,10
]}

Masters, Colin L. ^{[4
]}

Berkovic, Samuel F. ^{[27
]}

Collins, Steven ^{[5
,6
]}

Velakoulis, Dennis ^{[1
,2
,3
]}

机构：

[1] Royal Melbourne Hosp, Neuropsychiat, 300 Grattan St, Parkville, Vic 3050, Australia

[2] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia

[3] Univ Melbourne, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia

[4] Florey Inst Neurosci & Mental Hlth, Natl Dementia Diagnost Lab, Parkville, Vic, Australia

[5] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Australian Natl Creutzfeldt Jakob Dis Registry, Parkville, Vic, Australia

[6] Univ Melbourne, Dept Med, Parkville, Vic, Australia

[7] Royal Melbourne Hosp, Dept Med, Dept Neurol, Clin Outcomes Res Unit CORe, Parkville, Vic, Australia

[8] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Lund, Sweden

[9] Skane Univ Hosp, Memory Clin, Malmo, Sweden

[10] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia

[11] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia

[12] Deakin Univ, Sch Med, Geelong, Vic, Australia

[13] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia

[14] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia

[15] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Royal Melbourne Hosp, Parkville, Vic, Australia

[16] Univ Melbourne, Melbourne Brain Ctr, Dept Neurol, Royal Melbourne Hosp, Parkville, Vic, Australia

[17] Univ Melbourne, Dept Gen Practice, Integrated Mental Hlth Team, Parkville, Vic, Australia

[18] Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia

[19] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia

[20] Univ Melbourne, Austin Hlth, Comprehens Epilepsy Program, Heidelberg, Vic, Australia

[21] Monash Univ, Alfred Hosp, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia

[22] Alfred Hlth, Dept Psychiat, Melbourne, Vic, Australia

[23] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden

[24] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

[25] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England

[26] UCL, UK Dementia Res Inst, London, England

[27] Univ Melbourne, Epilepsy Res Ctr, Dept Med, Austin Hlth, Heidelberg, Vic, Australia

来源：

ALZHEIMERS & DEMENTIA | 2022年 / 18卷 / 11期

基金：

瑞典研究理事会; 澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;

关键词：

biomarker; dementia; diagnosis; neurofilament; neurology; psychiatric disorders; psychiatry; CREUTZFELDT-JAKOB-DISEASE; NEURODEGENERATIVE DEMENTIA; DIAGNOSTIC-ACCURACY; BIOMARKERS; TAU; CSF; PATHOLOGY; SEVERITY; PROTEIN;

D O I：

10.1002/alz.12549

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction Many patients with cognitive and neuropsychiatric symptoms face diagnostic delay and misdiagnosis. We investigated whether cerebrospinal fluid (CSF) neurofilament light (NfL) and total-tau (t-tau) could assist in the clinical scenario of differentiating neurodegenerative (ND) from psychiatric disorders (PSY), and rapidly progressive disorders. Methods Biomarkers were examined in patients from specialist services (ND and PSY) and a national Creutzfeldt-Jakob registry (Creutzfeldt-Jakob disease [CJD] and rapidly progressive dementias/atypically rapid variants of common ND, RapidND). Results A total of 498 participants were included: 197 ND, 67 PSY, 161 CJD, 48 RapidND, and 20 controls. NfL was elevated in ND compared to PSY and controls, with highest levels in CJD and RapidND. NfL distinguished ND from PSY with 95%/78% positive/negative predictive value, 92%/87% sensitivity/specificity, 91% accuracy. NfL outperformed t-tau in most real-life clinical diagnostic dilemma scenarios, except distinguishing CJD from RapidND. Discussion We demonstrated strong generalizable evidence for the diagnostic utility of CSF NfL in differentiating ND from psychiatric disorders, with high accuracy.

引用

页码：2218 / 2233

页数：16

共 50 条

[21] Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
Shahim, Pashtun
Blennow, Kaj
Johansson, Per
Svensson, Johan
Lista, Simone
Hampel, Harald
Andersson, Leif Christer
Zetterberg, Henrik
NEUROMOLECULAR MEDICINE, 2017, 19 (01) : 154 - 160
[22] Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting
Eratne, Dhamidhu
Kang, Matthew J. Y.
Lewis, Courtney
Dang, Christa
Malpas, Charles B.
Keem, Michael
Grewal, Jasleen
Marinov, Vladimir
Coe, Amy
Kaylor-Hughes, Cath
Borchard, Thomas
Keng-Hong, Chhoa
Waxmann, Alexandra
Saglam, Burcu
Kalincik, Tomas
Kanaan, Richard
Kelso, Wendy
Evans, Andrew
Farrand, Sarah
Loi, Samantha
Walterfang, Mark
Stehmann, Christiane
Li, Qiao-Xin
Collins, Steven
Masters, Colin L.
Santillo, Alexander F.
Zetterberg, Henrik
Blennow, Kaj
Berkovic, Samuel F.
Velakoulis, Dennis
ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7989 - 8001
[23] Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders
Geis, Tobias
Gutzeit, Svena
Disse, Sigrid
Kuhle, Jens
Fouzas, Sotiris
Wellmann, Sven
CHILDREN-BASEL, 2024, 11 (03):
[24] Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders
Bellomo, Giovanni
Indaco, Antonio
Chiasserini, Davide
Maderna, Emanuela
Paolini Paoletti, Federico
Gaetani, Lorenzo
Paciotti, Silvia
Petricciuolo, Maya
Tagliavini, Fabrizio
Giaccone, Giorgio
Parnetti, Lucilla
Di Fede, Giuseppe
FRONTIERS IN NEUROSCIENCE, 2021, 15
[25] Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases
Kawarabayashi, Takeshi
Nakamur, Takumi
Miyashit, Kazuya
Segaw, Tatsuya
Fukamachi, Isamu
Sugawara, Takashi
Oka, Hironori
Ishizawa, Kunihiko
Amari, Masakuni
Kasahara, Hiroo
Makioka, Kouki
Ikeda, Yoshio
Takatama, Masamitsu
Shoji, Mikio
JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (04) : 1623 - 1638
[26] Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
Irwin, David J.
Trojanowski, John Q.
Grossman, Murray
FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
[27] The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis
Forgrave, Lauren M.
Ma, Matthew
Best, John R.
DeMarco, Mari L.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 730 - 743
[28] Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease
Targa, Adriano
Dakterzada, Faride
Benitez, Ivan
Lopez, Ricard
Pujol, Montserrat
Dalmases, Mireia
Arias, Alfonso
Sanchez-de-la-Torre, Manuel
Zetterberg, Henrik
Blennow, Kaj
Pamplona, Reinald
Jove, Mariona
Barbe, Ferran
Pinol-Ripoll, Gerard
SLEEP, 2021, 44 (02)
[29] Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer’s Disease and Other Neurodegenerative Disorders
Pashtun Shahim
Kaj Blennow
Per Johansson
Johan Svensson
Simone Lista
Harald Hampel
Leif Christer Andersson
Henrik Zetterberg
NeuroMolecular Medicine, 2017, 19 : 154 - 160
[30] Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
Nilsson, Johanna
Cousins, Katheryn A. Q.
Gobom, Johan
Portelius, Erik
Chen-Plotkin, Alice
Shaw, Leslie M.
Grossman, Murray
Irwin, David J.
Trojanowski, John Q.
Zetterberg, Henrik
Blennow, Kaj
Brinkmalm, Ann
ALZHEIMERS & DEMENTIA, 2023, 19 (05) : 1775 - 1784

← 1 2 3 4 5 →